Skip to main content Skip to main navigation menu Skip to site footer

Albumin globulin ratio in children with dengue virus infection at Prof. Dr. R. D. Kandou Hospital, Manado Indonesia



Abstract

Backgrouns: Dengue virus infection (DVI) consists of mild-to-severe manifestations. The increasing hematocrit of 20% is used for detecting leakage of plasma, but it is a single parameter that is easily influenced by certain factors. It is necessary to examine the ratio of albumin/globulin which is more stable. The purpose of this study is to find out the ratio of albumin/globulin against various degrees of DVI. Methods: This is an analytic observational study with a cross-sectional and prospective cohort. The study was conducted at the Prof. Dr. R.D. Kandou Hospital, Pancaran Kasih Hospital, and R.W. Monginsidi Hospital from March 2013 to October 2014. The sample is obtained from at least 38 children for each group of DVI. Data were analyzed using SPSS 15, with significant value at p ≤ 0.05. Results: There were 164 children with DVI during the study, but we analyzed only 39 patients with DF, 39 patients with DHF, and 41 patients with DSS. All patients with DF had a albumin/globulin ratio ≥ 1.2, whereas 4 DHF patients and 5 DSS patients had a albumin/globulin ratio ≥ 1,2. Conclusions: There were significant differences in the ratio of albumin/globulin between DF, DHF, and DSS groups. It is emphasized that in the evaluation of plasma leakage using the ratio of albumin/globulin the changing levels of albumin should be considered. We should keep in mind also that there are other factors that can affect the synthesis of albumin.

Keywords: Ratio of albumin/globulin Dengue virus infection DF DHF DSS

References

  1. Bandyopadhyay S, Lum LCS, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO cases classification for dengue hemorrhagic fever. Trop Med IntHealth2006; 8:1238-55.
  2. Baratawidjaja KG. Basic immunology 7th eds. Faculty of Medicine, Indonesia University. Jakarta. 2006.
  3. Dewi BE, Takasaki T, Kurane I. Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol2008; 89:642-52.
  4. Guzman MG, Kouri G, Bravo J, Valdes L, Vasquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 2002; 6: 118-24.
  5. Hadinegoro SR, Moedjito I, Chairulfatah A. Guidelines for diagnosis and management of dengue viral infection in children. 1st eds. Book publisher from Indonesian Pediatric Association, Jakarta 2014; 37-42.
  6. Hottz E, Tolley ND, Zimmerman GA, Weyrich AS, Bozza FA. Platelets in dengue infection. 2011. DDMECdoi: 10.1016/j.ddmec.2011.09.001.
  7. Huang NT, Lan NT, Lei HY, et al. Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg 2005;72:370–4.
  8. Kalayanarooj S. Dengue classification: Current WHO vs the newly suggested classification for better clinical application? J Med AssocThai2011; 94(3):74-84.
  9. Kalayanarooj S, Nimmannitya S. Is dengue severity related to nutritional status?. Southeast Asian J Trop Med Public Health 2005; 36(2):378-84.
  10. Karyanti MR, Hadinegoro SR. Changes in the epidemiology of dengue hemorrhagic fever in Indonesia. Sari Pediatri 2009; 10:424-32.
  11. Kumar P. Grading of severity of the condition in burn patients by serum protein and albumin/globulin studies. Ann PlastSurg2010; 65(1):74-9.
  12. Kumar P, D’Souza J, Bhaskara KG, Bharadwaj S. Serum protein level in conjunction with serum albumin/globulin ratio as an indicator of severity of changes in capillary permeability. Burns2003; 29:628-9.
  13. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp ImmunolMicrobiol Infect Dis2007; 30:329-40.
  14. Luplertlop N, Misse D. MMP Cellular responses to dengueinfection-inducedvascularleakage. J Infect Dis2008; 61:298-301.
  15. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto H. Approximate sample size. Sastroasmoro S, Ismael S, ed. In: basics of clinical research methodology 4th eds. SagungSeto Jakarta 2011; 348-82.
  16. Maron GM, Clara AW, Diddle JW, et al.Association between nutritional status and severity of dengue infection in children in El Salvador. Am J Trop Med Hyg 2010; 82:324-9.
  17. Ministry of Health Indonesia. Indonesian Health Profile 2008.
  18. Mitchel M, Djamiatun K, Faradz SMH, Koenders MMJF, de Mast Q, Van der Ven AJAM. High plasma mid regional pro-andrenomedulin levels in children with severe dengue virus infections. J ClinVir2011; 50:8-12.
  19. Mitchel M, van der Ven AJAM, Djamiatun K, et al.Imbalance of Angiopoietin 1 and Angiopoietin-2in severe dengue and relationship with thrombocytopenia, endothelial activation and vascular stability. Am J Trop Hyg2012; 87(5):943-6.
  20. Ng CFS, Lum LCS, Ismail NA, Tan LH, Tan CPL. Clinician’s diagnostic practice of dengue infections. J ClinVirol2007; 40:202-6.
  21. Pawitan JA. Dengue virus infection: predictors for severe dengue. Acta Med Indones2011; 43:129-35.
  22. Pichainarong N, Mongkalangoon N, Kalayanarooj S, Chaveepojnkamjorn W. Relation between bodysize and severity of dengue hemorrhagic fever among children aged 0 – 14 years. Southeast Asian J Trop Med Public Health 2006; 37(2):283-8.
  23. Rampengan TH. Tropical infectious diseases in children 2nd eds. EGC, Jakarta 2008: 122-49.
  24. Saniathi E, Arhana BNP, Suandi IKG, Sidiartha IGL. Obesity as a risk factor of dengue shock syndrome. Sari Pediatri2009; 11:238-43.
  25. Srikiatkhachorn A. Plasma leakage in dengue dengue hemorrhagic fever. ThromHaemost 2009;102:1042-9.
  26. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, et al. Virus-induceddecline in solublevascularendothelialgrowthreceptor 2 is associated with plasmaleakage in denguehemorrhagicfever. J Virol2007; 81: 1592-600.
  27. Soedarmo SP. The problem of dengue hemorrhagic in Indonesia. In: Dengue hemorrhagic fever. Book publisher faculty of medicine, Indonesia University. Jakarta. 2005.
  28. Soegijanto S, Yotopranoto S, Salamun. Dengue hemorrhagic fever: overview and findings in new era 2013. Airlangga University Press.Surabaya. 2004.
  29. Sosothikul D, Seksran P, Pongsewalak S, Thisyakorn U, Lusher J. Activation of endothelial cells, coagulation andnfibrinolysis in children with Dengue virus infection. Thromb Haemost 2007; 97:627-34.
  30. Van der Weg CAM, Pannuti CS, Van den Ham HJ, et al. Serum Angiopoetin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection. J ClinVirol2014; 60:328-35.
  31. Wills BA, Dung NM, Loan HT. Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome. N Engl J Med 2004; 353; 9: 877–89.
  32. WHO. Dengue, dengue haemorrhagic fever and dengue shock syndrome in the context of the IMCI. WHO-FCH-CAH 2005.
  33. WHO. Update on the principles and use of rapid test in dengue. 2009.
  34. WHO. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. 2011.
  35. Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, Li RJ et al.Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 2012; 14(1):39–44.

How to Cite

Rampengan, N. H., Daud, D., Warouw, S., & Ganda, I. J. (2016). Albumin globulin ratio in children with dengue virus infection at Prof. Dr. R. D. Kandou Hospital, Manado Indonesia. Bali Medical Journal, 5(3), 562–567. https://doi.org/10.15562/bmj.v5i3.569
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
3

Total
1

Share

Search Panel

Novie Homenta Rampengan
Google Scholar
Pubmed
BMJ Journal

Dasril Daud
Google Scholar
Pubmed
BMJ Journal

Sarah Warouw
Google Scholar
Pubmed
BMJ Journal

Idham Jaya Ganda
Google Scholar
Pubmed
BMJ Journal